Open AccessIncrease in CD4 Count Among New Enrollees in HIV Care in the Modern Antiretroviral Therapy Era
Author(s) -
Charles Haines,
John A. Fleishman,
Baligh R. Yehia,
Stephen Berry,
Richard D. Moore,
Laura Bamford,
Kelly A. Gebo
Publication year - 2014
Publication title -
journal of acquired immune deficiency syndromes
Language(s) - English
Resource type - Journals
eISSN - 1944-7884
pISSN - 1525-4135
DOI - 10.1097/qai.0000000000000228
Subject(s) - medicine , confidence interval , antiretroviral therapy , cohort , guideline , human immunodeficiency virus (hiv) , retrospective cohort study , cohort study , pediatrics , viral load , demography , immunology , pathology , sociology
Earlier HIV diagnosis and engagement in care improve outcomes and is cost effective, as a result, in 2006, the Centers for Disease Control and Prevention (CDC) revised the HIV-screening guidelines. We sought to determine whether the CD4 count (CD4) at presentation, a surrogate for time to presentation, increased during the study period. Our a priori hypothesis was that the CD4 at presentation increased during the study period, particularly after the CDC guideline revision.